Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07202702 · ClinicalTrials.gov registry record · NA
Modulation of Motor Learning Via tDCS in a Dexterous Video Game Task
A NA study of Motor Activity, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT07202702: Recruiting NA study of Motor Activity, sponsored by Indiana University.
NCT07202702 is a NA study of Motor Activity that is actively recruiting participants, run by Indiana University. The registered enrollment target is 52 participants, below the 71-participant average among 6 other Motor Activity trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07202702, a NA study of Motor Activity, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether "transcranial direct current stimulation" (tDCS) is effective in enhancing learning of complex motor tasks of precision and accuracy that require the simultaneous coordination of both hands. The study will utilize a between-subjects, SHAM controlled design. Subjects will be randomly selected to receive either SHAM (n=26) or a-tDCS (n=26) stimulation and will be blinded to their condition throughout testing. Subjects will complete a total of two testing sessions, separated by \~24 hours. Both sessions will have the subject play the videogame "Guitar Hero", with a single song done for several trials as pre- and post-assessments. The first session will contain a 20-minute practice/stimulation block where subjects practice the guitar task while receiving either "active" or "inactive" stimulation of the motor cortex. The first session will last approximately 75 to 90 minutes whereas the second session will last approximately 15 to 20 minutes.
Primary Outcome
To determine whether a-tDCS influences motor skill acquisition of a dexterous video game task by measuring the outcome of videogame performance (number of notes played) with and without a-tDCS
Conditions Studied
Interventions
- DEVICE tDCS
Study Locations (1)
Indiana
- National Institute for Fitness and Sport - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2025-03-03 |
| Est. Completion | 2026-03-03 |
| Phase | NA |
What NCT07202702 shows while recruiting
NCT07202702 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 71-participant average among 6 other Motor Activity trials with a reported enrollment target (27% lower).
The record links to 1 condition, with Motor Activity appearing as the primary indexed condition, and to 1 intervention - of which tDCS is the first listed.
NCT07202702 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT07202702 about?
NCT07202702 is a clinical study titled "Modulation of Motor Learning Via tDCS in a Dexterous Video Game Task". The purpose of this study is to determine whether "transcranial direct current stimulation" (tDCS) is effective in enhancing learning of complex motor tasks of precision and accuracy that require the simultaneous coordination of both hands. The study will utilize a between-subjects, SHAM controlled ...
What is the current status of trial NCT07202702?
This trial is currently recruiting. It is a NA study. The enrollment target is 52 participants. The study started on 2025-03-03. Estimated completion is 2026-03-03.
What conditions does trial NCT07202702 study?
This clinical trial studies the following conditions: Motor Activity.
What interventions are being tested in trial NCT07202702?
The interventions under investigation include: tDCS (DEVICE).
Who is sponsoring clinical trial NCT07202702?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07202702 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Motor Activity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cranberry Polyphenols and Stress Resilience During Multitasking in Healthy Adults
RECRUITING · NA
-
Implementation of IVS3 for Upper Limb Motor Recovery
RECRUITING · NA
-
Unilateral M1 Anodal tDCS to Enhance Learning in a Gross Movement Videogame Task
ACTIVE NOT RECRUITING · NA
-
Fit Physicians: Use of Activity Monitors and Activity Integration Program in First Year Medical Students
COMPLETED · NA
-
Noninvasive VNS to Facilitate Excitability in Motor Cortex
COMPLETED · NA
-
Transcranial Direct Current Stimulation for Post-stroke Motor Recovery
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI